Last month details were published in a US journal after a study was conducted on an octavalent combination vaccine, both in the laboratory and in the field, containing inactivated Erysipelothrix rhusiopathiae, Parvovirus, and Leptospira interrogans (sensu lato) serogroups Canicola, Icterohaemorrhagiae, Australis (Bratislava), Grippotyphosa, Pomona and Tarassovi – Porcilis® Ery+Parvo+Lepto. Read more about the study here.
The EU are also slowly adapting. Read more here.